US HB3536 | 2017-2018 | 115th Congress

Status

Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on July 28 2017 - 25% progression, died in committee
Action: 2017-08-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Sponsors


History

DateChamberAction
2017-08-04HouseReferred to the Subcommittee on Health.
2017-07-28HouseReferred to the House Committee on Energy and Commerce.
2017-07-28HouseIntroduced in House

Same As/Similar To

SB1681 (Same As) 2017-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback